Concourse Financial Group Securities, Inc. Bioventus Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.56 Billion
Q2 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	BUY	$3.96 - $6.93 $0 - $0	0 New	0 $0
Q1 2024 Apr 30, 2024	BUY	$4.33 - $5.75 $0 - $0	0 New	0 $0
Q4 2023 Feb 07, 2024	BUY	$2.89 - $5.34 $0 - $0	0 New	0 $0
Q3 2023 Oct 30, 2023	BUY	$2.8 - $4.94 $0 - $0	0 New	0 $0
Q3 2023 Oct 25, 2023	BUY	$2.8 - $4.94 $0 - $0	0 New	0 $0
Q2 2023 Aug 10, 2023	BUY	$0.93 - $3.64 $0 - $0	0 New	0 $0
Q1 2023 May 15, 2023	BUY	$1.07 - $2.95 $0 - $0	0 New	0 $0
Q4 2022 Jan 30, 2023	SELL	$1.81 - $8.14 $1,154 - $5,193	-638 Closed	0 $0
Q3 2022 Nov 15, 2022	BUY	$6.54 - $9.08 $477 - $662	73 Added 12.92%	638 $4,000
Q2 2022 Aug 09, 2022	BUY	$6.82 - $13.82 $3,853 - $7,808	565 New	565 $4,000
Q1 2022 May 09, 2022	BUY	$11.65 - $15.28 $0 - $0	0 New	0 $0
Q4 2021 Feb 07, 2022	BUY	$12.37 - $16.77 $0 - $0	0 New	0 $0
Q3 2021 Nov 09, 2021	BUY	$13.7 - $17.25 $0 - $0	0 New	0 $0
Q2 2021 Aug 13, 2021	BUY	$13.75 - $18.8 $0 - $0	0 New	0 $0
Q1 2021 May 13, 2021	BUY	$11.49 - $19.21 $0 - $0	0 New	0 $0

Others Institutions Holding BVS

# of Institutions

107

Shares Held

39.9M

Call Options Held

138K

Put Options Held

137K

Essex Woodlands Management, Inc. The Woodlands, TX

13M
Shares

$151 Million
24.48% of portfolio
Juniper Investment Company, LLC New York, NY

6.83M
Shares

$79.2 Million
18.67% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

5.34M
Shares

$61.9 Million
2.05% of portfolio
Black Rock Inc. New York, NY

2.37M
Shares

$27.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.66M
Shares

$19.2 Million
0.0% of portfolio

View Full List

About Bioventus Inc.

Ticker BVS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 61,664,200
Market Cap $715M
Description
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...

More about BVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account